Stop TB Partnership

TB REACH

Wave 9

In July 2021, Stop TB Partnership’s Executive Committee approved US$6.14 million for Wave 9 funding to be awarded to 11 projects, in 8 countries, to focus their efforts on innovative approaches to address drug resistant tuberculosis (DRTB).With funding support from USAID and Global Affairs Canada, TB REACH Wave 9 grantees will help reduce initial or pre-treatment loss to follow up for people with DR-TB, by expanding access to new, all-oral treatment regimens, and improving treatment adherence and outcomes for people with DR-TB.

In Wave 9, only local, non-governmental organizations were eligible for funding, and together with the support of USAID, TB REACH will work with the organizations on a capacity assessment as part of a development plan to help grantees to improve and continue their funding efforts.

The Wave 9 Call for Proposals was launched in January 2021 and received almost 300 applications from 24 countries with a total funding request of USD 145 million. All completed proposals were reviewed intensively by an independent Proposal Review Committee (PRC), who selected 48 applicants to be invited to submit a more in-depth stage 2 proposal. These applications underwent another round of diligent and careful review by the PRC. After an 8-day review meeting, the PRC recommended 11 projects from 8 countries for funding.

TB REACH Wave 9 Grantees

Organization	Country	Project Category	Requested Budget (USD)
Interactive Research & Development Ltd.	Bangladesh	Implementation of new DR-TB treatment regimens	$600,000
REACH Ethiopia	Ethiopia	Improving treatment adherence and outcomes	$590,037
Baptist Church Trust Association (BCTA)	India	Improving treatment adherence and outcomes	$580,294
Innovators In Health (India)	India	Linkage to care to reduce pre-treatment loss to follow-up	$593,066
Resource Group for Education and Advocacy for Community Health	India	Linkage to care to reduce pre-treatment loss to follow-up	$584,286
Population Services Kenya	Kenya	Improving treatment adherence and outcomes	$600,000
RedAid Nigeria	Nigeria	Linkage to care to reduce pre-treatment loss to follow-up	$213,459
Janna Health Foundation	Nigeria	Improving treatment adherence and outcomes	$582,398
DOPASI Foundation	Pakistan	Improving treatment adherence and outcomes	$598,819
CTY TNHH (IRD VN)	Viet Nam	Implementation of new DR-TB treatment regimens	$600,000
The Union Zimbabwe Trust	Zimbabwe	Implementation of new DR-TB treatment regimens	$599,995